The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Harvey, Richard M ^a   Hughes, Catherine E ^a   Paton, Adrienne W ^a   Trappetti, Claudia ^a   Tweten, Rodney K ^b   Paton, James C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 23P19; PNEUMOLYSIN; PROTEIN P19; BACTERIAL PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; PRIMER DNA; STREPTOLYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; FEMALE; GENE EXPRESSION REGULATION; GM CSF GENE; IFN BETA GENE; IL23A GENE; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGES; MICE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84905659601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103625     Document Type: Article

References (54)

1. Alexander JE, Lock RA, Peeters CC, Poolman JT, Andrew PW, et al. (1994) Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62: 5683-5688. (Pubitemid 24365020)
2. Arevalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, et al. (2009) Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung. FEMS Immunol Med Microbiol 55: 346-351.
3. Kirkham LA, Kerr AR, Douce GR, Paterson GK, Dilts DA, et al. (2006) Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect Immun 74: 586-593. (Pubitemid 43023114)
4. Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC (2000) Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun 68: 3028-3033. (Pubitemid 30253892)
5. Paton JC, Lock RA, Hansman DJ (1983) Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun 40: 548-552. (Pubitemid 13133264)
6. Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, et al. (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.
7. Berry AM, Yother J, Briles DE, Hansman D, Paton JC (1989) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037-2042. (Pubitemid 19186880)
8. Canvin JR, Marvin AP, Sivakumaran M, Paton JC, Boulnois GJ, et al. (1995) The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172: 119-123.
9. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, et al. (2000) Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68: 492-501. (Pubitemid 30056499)
10. Berry AM, Alexander JE, Mitchell TJ, Andrew PW, Hansman D, et al. (1995) Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae . Infect Immun 63: 1969-1974.
11. Braun JS, Novak R, Gao G, Murray PJ, Shenep JL (1999) Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 67: 3750-3756. (Pubitemid 29356987)
12. Cockeran R, Theron AJ, Steel HC, Matlola NM, Mitchell TJ, et al. (2001) Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 183: 604-611. (Pubitemid 32147516)
13. Houldsworth S, Andrew PW, Mitchell TJ (1994) Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62: 1501-1503.
14. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, et al. (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100: 1966-1971. (Pubitemid 36254557)
15. Paton JC, Rowan-Kelly B, Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43: 1085-1087. (Pubitemid 14192004)
16. Shak JR, Ludewick HP, Howery KE, Sakai F, Yi H, et al. (2013) Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of Biofilms. MBio 4.
17. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, et al. (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191.
18. Antonio M, Hakeem I, Awine T, Secka O, Sankareh K, et al. (2008) Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol 8: 198.
19. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432. (Pubitemid 36549688)
20. Leimkugel J, Adams Forgor A, Gagneux S, Pfluger V, Flierl C, et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 192: 192-199. (Pubitemid 40993388)
21. Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, et al. (2004) Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 189: 785-796. (Pubitemid 38328178)
22. Sjostrom K, Spindler C, Ortqvist A, Kalin M, Sandgren A, et al. (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 42: 451-459. (Pubitemid 43202515)
23. Yaro S, Lourd M, Traore Y, Njanpop-Lafourcade BM, Sawadogo A, et al. (2006) Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis 43: 693-700. (Pubitemid 44330730)
24. Duarte C, Sanabria O, Moreno J (2013) Molecular characterization of Streptococcus pneumoniae serotype 1 invasive isolates in Colombia. Rev Panam Salud Publica 33: 422-426.
25. Kirkham LA, Jefferies JM, Kerr AR, Jing Y, Clarke SC, et al. (2006) Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol 44: 151-159. (Pubitemid 43100594)
26. Lai JY, Cook H, Yip TW, Berthelsen J, Gourley S, et al. (2013) Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012. BMC Infect Dis 13: 409.
27. Le Hello S, Watson M, Levy M, Marcon S, Brown M, et al. (2010) Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007. J Clin Microbiol 48: 2968-2971.
28. Marimon JM, Ercibengoa M, Alonso M, Zubizarreta M, Perez-Trallero E (2009) Clonal structure and 21-year evolution of Streptococcus pneumoniae serotype 1 isolates in northern Spain. Clin Microbiol Infect 15: 875-877.
29. Harvey RM, Ogunniyi AD, Chen AY, Paton JC (2011) Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect Immun 79: 4122-4130.
30. Harvey RM, Stroeher UH, Ogunniyi AD, Smith-Vaughan HC, Leach AJ, et al. (2011) A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence. PLoS One 6: e19650.
31. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, et al. (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187: 434-440.
32. Farrand AJ, LaChapelle S, Hotze EM, Johnson AE, Tweten RK (2010) Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci U S A 107: 4341-4346.
33. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5: e8668.
34. Riendeau CJ, Kornfeld H (2003) THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun 71: 254-259. (Pubitemid 36026027)
35. Avery OT, Macleod CM, McCarty M (1944) Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types : Induction of Transformation by a Desoxyribonucleic Acid Fraction Isolated from Pneumococcus Type Iii. J Exp Med 79: 137-158.
36. Weiser JN, Austrian R, Sreenivasan PK, Masure HR (1994) Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62: 2582-2589. (Pubitemid 24157093)
37. Lacks S, Hotchkiss RD (1960) A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta 39: 508-518.
38. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z, et al. (1993) Gene splicing by overlap extension. Methods Enzymol 217: 270-279. (Pubitemid 23173375)
39. Morona JK, Miller DC, Morona R, Paton JC (2004) The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J Infect Dis 189: 1905-1913. (Pubitemid 38657227)
40. Martin B, Garcia P, Castanie MP, Glise B, Claverys JP (1995) The recA gene of Streptococcus pneumoniae is part of a competence-induced operon and controls an SOS regulon. Dev Biol Stand 85: 293-300.
41. Giammarinaro P, Paton JC (2002) Role of RegM, a homologue of the catabolite repressor protein CcpA, in the virulence of Streptococcus pneumoniae. Infect Immun 70: 5454-5461.
42. Morona JK, Paton JC, Miller DC, Morona R (2000) Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol Microbiol 35: 1431-1442. (Pubitemid 30175519)
43. Sung CK, Li H, Claverys JP, Morrison DA (2001) An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae . Appl Environ Microbiol 67: 5190-5196. (Pubitemid 33701288)
44. Kadioglu A, Andrew PW (2004) The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 25: 143-149. (Pubitemid 38249488)
45. Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8: 533-544.
46. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
47. Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286. (Pubitemid 46687011)
48. Trzcinski K, Thompson CM, Srivastava A, Basset A, Malley R, et al. (2008) Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 76: 2678-2684.
49. Zhang Z, Clarke TB, Weiser JN (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909.
50. Koppe U, Hogner K, Doehn JM, Muller HC, Witzenrath M, et al. (2012) Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. J Immunol 188: 811-817.
51. Brasier AR, Jamaluddin M, Casola A, Duan W, Shen Q, et al. (1998) A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. J Biol Chem 273: 3551-3561. (Pubitemid 28109779)
52. Calbo E, Garau J (2010) Of mice and men: innate immunity in pneumococcal pneumonia. Int J Antimicrob Agents 35: 107-113.
53. Kasahara T, Mukaida N, Yamashita K, Yagisawa H, Akahoshi T, et al. (1991) IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74: 60-67.
54. Sonoda Y, Kasahara T, Yamaguchi Y, Kuno K, Matsushima K, et al. (1997) Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-kappaB activation. J Biol Chem 272: 15366-15372. (Pubitemid 27255560)